Literature DB >> 20595739

Verbal fluency deficits co-occur with memory deficits in geriatric patients at risk for dementia: Implications for the concept of mild cognitive impairment.

Maria E Cottingham1, Keith A Hawkins.   

Abstract

We tested the notion that patients at high risk for progression to Alzheimer's disease (AD) display relatively isolated memory deficits by assessing the relationship between memory and fluency performances in a sample of 92 geriatric subjects with cognitive complaints and normal to mild clinical presentations. Patient groups were formed on the basis of memory test scores. Patients with normal memory scores also performed normally on fluency tests, and their fluency scores were significantly higher than those of patients with low memory performances. Patients falling between these two groups in memory abilities also displayed intermediate level fluency performances. Whereas the normal memory group performed at equivalent levels on semantic and phonemic fluency tasks, both the impaired memory group and the intermediate group displayed relatively greater weaknesses in semantic fluency. This pattern is similar to that seen in AD. Since the impaired memory patients meet criteria for Amnestic Mild Cognitive Impairment, these findings suggest that memory deficits in "pre-clinical" AD are likely to be accompanied by fluency weaknesses, with semantic fluency weaknesses predominating.

Entities:  

Mesh:

Year:  2010        PMID: 20595739      PMCID: PMC5434323          DOI: 10.3233/ben-2009-0246

Source DB:  PubMed          Journal:  Behav Neurol        ISSN: 0953-4180            Impact factor:   3.342


  6 in total

1.  Normative Data for Derived Measures and Discrepancy Scores for the Uniform Data Set 3.0 Neuropsychological Battery.

Authors:  Paulina V Devora; Samantha Beevers; Andrew M Kiselica; Jared F Benge
Journal:  Arch Clin Neuropsychol       Date:  2019-01-24       Impact factor: 2.813

2.  APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.

Authors:  Ignacio F Mata; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Howard I Hurtig; Vivianna M Van Deerlin; Beate Ritz; Rebecca Rausch; Shannon L Rhodes; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Amie L Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; Shu-Ching Hu; Brenna A Cholerton; Jia Y Wan; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

3.  Similar verbal fluency patterns in amnestic mild cognitive impairment and Alzheimer's disease.

Authors:  Edmond Teng; Judith Leone-Friedman; Grace J Lee; Stephanie Woo; Liana G Apostolova; Shelly Harrell; John M Ringman; Po H Lu
Journal:  Arch Clin Neuropsychol       Date:  2013-06-09       Impact factor: 2.813

4.  The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitors.

Authors:  George T Grossberg; Facundo Manes; Ricardo F Allegri; Luis Miguel Gutiérrez-Robledo; Sergio Gloger; Lei Xie; X Daniel Jia; Vojislav Pejović; Michael L Miller; James L Perhach; Stephen M Graham
Journal:  CNS Drugs       Date:  2013-06       Impact factor: 5.749

5.  Impaired generation of new subcategories and switching in a semantic verbal fluency test in older adults with mild cognitive impairment.

Authors:  Laiss Bertola; Maria Luiza Cunha Lima; Marco A Romano-Silva; Edgar N de Moraes; Breno Satler Diniz; Leandro F Malloy-Diniz
Journal:  Front Aging Neurosci       Date:  2014-07-01       Impact factor: 5.750

6.  Effect of Supplementation of a Whey Peptide Rich in Tryptophan-Tyrosine-Related Peptides on Cognitive Performance in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Masahiro Kita; Kuniaki Obara; Sumio Kondo; Satoshi Umeda; Yasuhisa Ano
Journal:  Nutrients       Date:  2018-07-13       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.